Skip to main content
. 2021 Oct 9;13(10):1649. doi: 10.3390/pharmaceutics13101649

Figure 9.

Figure 9

Responsive nanoparticles for endosomal membrane disruption and cell membrane fusion. (A) Preparation, cytoplasmic delivery, and gene editing efficiency of Cas9 RNP/ZIF (Reproduced with permission from [66]. Copyright ACS Publications, 2018). (B) Rational engineering of Cas9 protein and ArgNPs for intracellular delivery of Cas9-RNP via membrane fusion (Reproduced with permission from [69]. Copyright ACS Publications, 2017).